Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy

被引:161
|
作者
McCully, RB [1 ]
Nishimura, RA [1 ]
Tajik, AJ [1 ]
Schaff, HV [1 ]
Danielson, GK [1 ]
机构
[1] MAYO CLIN & MAYO FDN,DIV THORAC & CARDIOVASC SURG,ROCHESTER,MN 55905
关键词
cardiomyopathy; echocardiography; myectomy; mortality; surgery;
D O I
10.1161/01.CIR.94.3.467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A subgroup of patients with hypertrophic obstructive cardiomyopathy remain severely symptomatic despite optimal medical therapy. Septal myectomy reduces or eliminates left ventricular outflow obstruction and produces marked symptomatic improvement. With the recent advent of alternative methods for treatment of this disorder, such as dual-chamber pacing, it is necessary to establish the risks and benefits of septal myectomy in the modem surgical era. Methods and Results The clinical, EGG, echocardiographic, cardiac catheterization, and surgical data were analyzed for 65 patients 20 to 70 years old with hypertrophic obstructive cardiomyopathy who had surgical treatment between 1986 and 1992. Specific symptoms and overall functional status were evaluated before surgery and at the end of the first postoperative year. Subsequent long-term clinical postoperative follow-up was also obtained. The extent of postoperative improvement was measured by the presence and severity of persistent symptoms, overall New York Heart Association (NYHA) functional class, and patients' self-perceptions of overall improvement. Of the patients, 95% were in NYHA functional class LU or TV before surgery: 95% had dyspnea, 62% had angina, 63% had near-syncope, and 23% had syncope. The overall early mortality rate was 4.6%; there was no mortality among the 45 patients who underwent isolated septal myectomy. At the 1-year postoperative evaluation, 89% of survivors were in NYHA functional class I or II, and 47% believed that they had 100% improvement. Significant improvement (as defined) was seen in 67% of patients with dyspnea, 90% with angina, 86% with near-syncope, and 100% with syncope. The 5-year survival rate was 92%. Conclusions The results of the present study reaffirm the efficacy of surgical treatment of hypertrophic obstructive cardiomyopathy in patients who are severely symptomatic despite optimal medical therapy and serve as a useful reference by which the surgical approach can be compared with new and potentially promising treatment alternatives.
引用
收藏
页码:467 / 471
页数:5
相关论文
共 50 条
  • [21] Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy
    Kappenberger, LJ
    Linde, C
    Jeanrenaud, X
    Daubert, C
    McKenna, W
    Meisel, E
    Sadoul, N
    Chojnowska, L
    Guize, L
    Gras, D
    Aebischer, N
    Gadler, F
    Rydén, L
    [J]. EUROPACE, 1999, 1 (02): : 77 - 84
  • [22] Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy
    Wells, Sophie
    Rowin, Ethan J.
    Boll, Griffin
    Rastegar, Hassan
    Wang, Wendy
    Maron, Martin S.
    Maron, Barry J.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2018, 131 (06): : E234 - E239
  • [23] LONG-TERM FOLLOW UP AFTER SURGICAL TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    ROTHLIN, M
    ARBENZ, U
    KRAYENBUHL, HP
    TURINA, J
    SENNING, A
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1976, 65 (06): : 501 - 510
  • [24] Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy
    Bougioukas, Ioannis
    Hoppe, Uta
    Danner, Bernhard
    Schoendube, Friedrich A.
    [J]. THORACIC AND CARDIOVASCULAR SURGEON REPORTS, 2016, 5 (01): : 30 - 32
  • [25] Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy A Clinical Trial
    Heitner, Stephen B.
    Jacoby, Daniel
    Lester, Steven J.
    Owens, Anjali
    Wang, Andrew
    Zhang, David
    Lambing, Joseph
    Lee, June
    Semigran, Marc
    Sehnert, Amy J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2019, 170 (11) : 741 - +
  • [26] ROLE OF DRUG THERAPY IN SURGICAL TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Abrolov, H. K.
    Mirsaidov, M. M.
    Alimov, A. B.
    Murodov, U. A.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S65 - S65
  • [27] Hypertrophic obstructive cardiomyopathy in pediatric patients: Results of surgical treatment
    Theodoro, DA
    Danielson, GK
    Feldt, RH
    Anderson, BJ
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (06): : 1589 - 1597
  • [28] RESULTS OF SURGICAL TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY OF LEFT VENTRICLE
    VERBIEST, EL
    SNELLEN, HA
    HARTMAN, H
    ROOS, JP
    [J]. BRITISH HEART JOURNAL, 1968, 30 (03): : 422 - &
  • [29] Surgical treatment of hypertrophic obstructive cardiomyopathy in children by a new approach
    Bockeria, LA
    Borisov, K
    Sinyov, AF
    Zlotchevskaya, EV
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 558 - 558
  • [30] Interdisciplinary approach to surgical treatment for patients with hypertrophic obstructive cardiomyopathy
    Rudenko, K., V
    Nevmerzhytska, L. O.
    Kozhanov, M., V
    Tregubova, M. O.
    Danchenko, P. A.
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (04) : 492 - 502